In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PharmaEngine Inc.

Latest From PharmaEngine Inc.

Pipeline Watch: Phase III Progress With Avelumab, Brimapitide, Inhaled Amikacin

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Ipsen Pays $575m Upfront For Struggling Pancreatic Drug Onivyde

Ipsen's new CEO David Meek has conducted the French company's biggest ever deal by acquiring Onivyde for pancreatic cancer from Merrimack Pharmaceuticals, and believes Ipsen will turn Onivyde's fortunes around.

Commercial Deals

PIPELINE WATCH: New Diabetes Therapy Studied In China, DARPins Progress In Eye Disease

Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.

Pipeline Watch Approvals

Merrimack's Slow Ramp-up For Onivyde Prompts Cutbacks

CEO removed as part of 22% staff cut as Merrimack looks to increase runway while awaiting data to add first-line pancreatic cancer to the Onivyde label.

Leadership Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Taiwan
  • Parent & Subsidiaries
  • PharmaEngine Inc.
  • Senior Management
  • C. Grace Yeh, PhD, Pres. & CEO
    C.S. Chang, Sr. Dir., Fin. & Admin.
  • Contact Info
  • PharmaEngine Inc.
    Phone: (886) 2 2515 8228
    16F, 237 Sung-Chiang Rd.
    Taipei, 104